These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 14648452)

  • 1. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
    Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
    De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamics of the human immunodeficiency virus epidemics in the south of Brazil: increasing role of injection drug users.
    Caiaffa WT; Proietti FA; Carneiro-Proietti AB; Mingoti SA; Doneda D; Gandolfi D; Reis AC;
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S376-81. PubMed ID: 14648451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus/acquired immunodeficiency syndrome prevention in injection drug users and their partners and children: lessons learned in Latin America--the Argentinean case.
    Rossi D; Goltzman P; Cymerman P; Touzé G; Weissenbacher M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S362-5. PubMed ID: 14648448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.
    Donoghoe MC; Bollerup AR; Lazarus JV; Nielsen S; Matic S
    Int J Drug Policy; 2007 Aug; 18(4):271-80. PubMed ID: 17689375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.
    Inchaurraga S
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S366-71. PubMed ID: 14648449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of HIV/AIDS among injection drug users: the theory and science of public health and criminal justice approaches to disease prevention.
    Gostin LO; Lazzarini Z
    Emory Law J; 1997; 46(2):587-696. PubMed ID: 11769762
    [No Abstract]   [Full Text] [Related]  

  • 10. Obstacles to the development of prevention and public health policies in Argentina.
    Touzé G
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired immunodeficiency syndrome in Brazil.
    Meira DA
    Croat Med J; 2002 Aug; 43(4):475-9. PubMed ID: 12187527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

  • 13. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction, HIV and development.
    Deany P; Crofts N
    Dev Bull; 2000 Jun; (52):45-8. PubMed ID: 12179450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis for epidemic trend of acquired immunodeficiency syndrome in Yunnan Province of China].
    Lu L; Jia MH; Zhang XB; Luo HB; Ma YL; Fu LR; Lu JY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):309-12. PubMed ID: 15498242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HIV epidemic in China: history, response, and challenge.
    He N; Detels R
    Cell Res; 2005; 15(11-12):825-32. PubMed ID: 16354555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection drug use and HIV/AIDS transmission in China.
    Chu TX; Levy JA
    Cell Res; 2005; 15(11-12):865-9. PubMed ID: 16354561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.